Takeda Pharmaceutical Co Ltd (4502) - Financial and Strategic SWOT Analysis Review

  • ID: 1292073
  • SWOT Analysis
  • 69 pages
  • GlobalData
  • Takeda Pharmaceutical Company Limited
1 of 5

FEATURED COMPANIES

  • Astellas Pharma Inc
  • Eisai Co Ltd
  • GTx Inc
  • MORE
Takeda Pharmaceutical Co Ltd (4502) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analysts summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Takeda Pharmaceutical Company Ltd (Takeda) is a research-based global pharmaceutical company which focuses on the research and development, manufacture, marketing, commercialization and import and export of pharmaceutical drugs and consumer health care products. The company manufactures and markets a wide range of products including photographic chemicals, inorganic chemicals, vitamin bulks, test reagents and clinical diagnostics. Takeda markets its drugs worldwide through its subsidiaries in North America, Europe and Asia. It operates production facilities in Osaka and Hikari in Japan; Italy; Ireland; Germany; Austria; Denmark; Belgium; Norway; Poland; Russia; China; Indonesia; Mexico; Brazil; Argentina; Columbia; Estonia; and India. It also operates research and development facilities at various locations in Japan and the US, China and the UK; and in Brazil, Germany, Switzerland, and Singapore. Takeda is headquartered in Chuo-ku, Osaka, Japan.

Takeda Pharmaceutical Co Ltd Key Recent Developments

Aug 10, 2018: Ambys Medicines and Takeda to develop new therapies for liver diseases
Aug 03, 2018: Takeda and Whiz Partners announce creation of joint investment fund, fund aims to promote drug discovery ecosystem in Japan
Aug 02, 2018: Takeda closes TiGenix acquisition for about $608m
Jul 31, 2018: Takeda reports first quarter financial result 2018 results
Jul 17, 2018: leon-nanodrugs supports Takeda in a feasibility assessment of leon’s proprietary MicroJet Reactor (MJR) nano-technology

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Astellas Pharma Inc
  • Eisai Co Ltd
  • GTx Inc
  • MORE
Section 1 - About the Company
  • Takeda Pharmaceutical Co Ltd - Key Facts
  • Takeda Pharmaceutical Co Ltd - Key Employees
  • Takeda Pharmaceutical Co Ltd - Key Employee Biographies
  • Takeda Pharmaceutical Co Ltd - Major Products and Services
  • Takeda Pharmaceutical Co Ltd - History
  • Takeda Pharmaceutical Co Ltd - Company Statement
  • Takeda Pharmaceutical Co Ltd - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
  • Joint Venture
Section 2 – Company Analysis
  • Company Overview
  • Takeda Pharmaceutical Co Ltd - Business Description
  • Business Segment: Pharmaceutical Products
  • Overview
  • Performance
  • Geographical Segment: Asia
  • Performance
  • Geographical Segment: Europe and Canada
  • Performance
  • Geographical Segment: Japan
  • Performance
  • Geographical Segment: Latin America
  • Performance
  • Geographical Segment: Other
  • Performance
  • Geographical Segment: Russia/CIS
  • Performance
  • Geographical Segment: The US
  • Performance
  • Takeda Pharmaceutical Co Ltd - SWOT Analysis
  • SWOT Analysis - Overview
  • Takeda Pharmaceutical Co Ltd - Strengths
  • Takeda Pharmaceutical Co Ltd - Weaknesses
  • Takeda Pharmaceutical Co Ltd - Opportunities
  • Takeda Pharmaceutical Co Ltd - Threats
  • Takeda Pharmaceutical Co Ltd - Key Competitors
Section 3 – Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
  • Takeda Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
  • Takeda Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
  • Takeda Pharmaceutical Co Ltd, Recent Deals Summary
Section 5 – Company’s Recent Developments
  • Aug 10, 2018: Ambys Medicines and Takeda to develop new therapies for liver diseases
  • Aug 10, 2018: Ambys Medicines and Takeda to develop new therapies for liver diseases
  • Aug 03, 2018: Takeda and Whiz Partners announce creation of joint investment fund, fund aims to promote drug discovery ecosystem in Japan
  • Aug 02, 2018: Takeda closes TiGenix acquisition for about $608m
  • Jul 31, 2018: Takeda reports first quarter financial result 2018 results
  • Jul 17, 2018: leon-nanodrugs supports Takeda in a feasibility assessment of leon’s proprietary MicroJet Reactor (MJR) nano-technology
  • Jul 11, 2018: Takeda Selected by the FTSE4Good Developed Index for the 14th Consecutive Year
  • Jul 09, 2018: Takeda Announces Selection of Three New Programs for Global Corporate Social Responsibility CSR Program 2018 Promoting Disease Prevention to Improve Health in Developing and Emerging Countries
  • Jul 02, 2018: Takeda Global Headquarters Grand Opening
  • Jun 28, 2018: Takeda: New Assignments of Directors
Section 6 – Appendix
  • Methodology
  • Ratio Definitions
  • About
  • Contact
  • Disclaimer
List of Tables
  • Takeda Pharmaceutical Co Ltd, Key Facts
  • Takeda Pharmaceutical Co Ltd, Key Employees
  • Takeda Pharmaceutical Co Ltd, Key Employee Biographies
  • Takeda Pharmaceutical Co Ltd, Major Products and Services
  • Takeda Pharmaceutical Co Ltd, History
  • Takeda Pharmaceutical Co Ltd, Other Locations
  • Takeda Pharmaceutical Co Ltd, Subsidiaries
  • Takeda Pharmaceutical Co Ltd, Joint Venture
  • Takeda Pharmaceutical Co Ltd, Key Competitors
  • Takeda Pharmaceutical Co Ltd, Ratios based on current share price
  • Takeda Pharmaceutical Co Ltd, Annual Ratios
  • Takeda Pharmaceutical Co Ltd, Annual Ratios
  • Takeda Pharmaceutical Co Ltd, Annual Ratios
  • Takeda Pharmaceutical Co Ltd, Interim Ratios
  • Takeda Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
  • Takeda Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
  • Takeda Pharmaceutical Co Ltd, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Takeda Pharmaceutical Co Ltd, Performance Chart (2014 - 2018)
  • Takeda Pharmaceutical Co Ltd, Ratio Charts
  • Takeda Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
  • Takeda Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • Taisho Pharmaceutical Holdings Co Ltd
  • Santen Pharmaceutical Co Ltd
  • Rohto Pharmaceutical Co Ltd
  • Mochida Pharmaceutical Co Ltd
  • Kaken Pharmaceutical Co Ltd
  • GTx Inc
  • Eisai Co Ltd
  • Chugai Pharmaceutical Co Ltd
  • Astellas Pharma Inc
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll